**Core Concept**
Nimodipine is a calcium channel blocker (CCB) that selectively inhibits L-type calcium channels, primarily affecting vascular smooth muscle and to some extent, cardiac muscle. This action results in vasodilation, which can be beneficial in specific clinical conditions.

**Why the Correct Answer is Right**
Nimodipine's major clinical use is in the management of subarachnoid hemorrhage, a type of stroke caused by bleeding into the space surrounding the brain. This condition often leads to vasospasm, a severe constriction of blood vessels that can result in cerebral ischemia and further brain damage. Nimodipine's ability to inhibit calcium influx into vascular smooth muscle cells helps prevent or alleviate this vasospasm, thereby improving cerebral blood flow and reducing the risk of ischemic complications. The selective action of nimodipine on L-type calcium channels minimizes its effects on cardiac muscle, making it a safer choice for patients with subarachnoid hemorrhage.

**Why Each Wrong Option is Incorrect**
**Option A:** Raynaud's phenomenon is a condition characterized by vasospastic episodes, but it is typically managed with other agents that more effectively address the underlying pathophysiology, such as nitrates or phosphodiesterase inhibitors.
**Option B:** Hypertension is often treated with other classes of calcium channel blockers, such as amlodipine or verapamil, which have a broader range of action on L-type calcium channels and are more effective in lowering blood pressure.
**Option C:** Angina is typically managed with agents that more effectively reduce myocardial oxygen demand, such as beta blockers or nitrates, rather than calcium channel blockers.

**Clinical Pearl / High-Yield Fact**
Nimodipine is a good example of a drug that has a specific, targeted action in a particular clinical condition, making it a high-yield fact for pharmacology exams.

**✓ Correct Answer: D. Subarachnoid haemorrhage**